These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1712273)

  • 21. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
    Banas JS
    Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of cilazapril on endothelial function and pulmonary hypertension in patients with congestive heart failure.
    Tavli T; Gocer H
    Jpn Heart J; 2002 Nov; 43(6):667-74. PubMed ID: 12558130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cilazapril: an overview of its efficacy and safety in hypertension.
    Szucs T; Schneeweiss A
    Cardiology; 1992; 80(1):34-41. PubMed ID: 1532534
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The 24 h blood pressure responses of hypertensives to a once-a-day cilazapril regimen.
    Fernandez PG; Bolli P; Lee C
    Can J Cardiol; 1990 Mar; 6(2):53-8. PubMed ID: 2138051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure.
    Kelbaek H; Agner E; Wroblewski H; Vasehus Madsen P; Marving J
    Eur Heart J; 1993 May; 14(5):692-5. PubMed ID: 8508863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute effects of cilazapril on coronary hemodynamics in patients with renovascular hypertension.
    Magrini F; Reggiani P; Fratianni G; Morganti A; Zanchetti A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S128-33. PubMed ID: 1381789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic effects of lisinopril after long-term administration in congestive heart failure.
    Stone CK; Uretsky BF; Linnemeier TJ; Shah PK; Amin DK; Snapinn SM; Rush JE; Langendörfer A; Liang CS
    Am J Cardiol; 1989 Mar; 63(9):567-70. PubMed ID: 2537566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The acute effects of cilazapril on pulmonary function tests and arterial blood gas changes in patients with pulmonary hypertension.
    Tavli T; Sekuri C; Goktalay T; Uyanik BS; Ari Z
    Int J Clin Pharmacol Res; 2003; 23(2-3):53-9. PubMed ID: 15018019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cilazapril on ventricular arrhythmia in patients with congestive heart failure.
    Hattori Y; Atsushi S; Hiroaki F; Toyama J
    Clin Ther; 1997; 19(3):481-6. PubMed ID: 9220212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pharmacokinetic study of cilazapril in patients with congestive heart failure.
    Rosenthal E; Francis RJ; Brown AN; Rajaguru S; Williams PE; Steiner J; Curry PV
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):267S-273S. PubMed ID: 2548554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of cilazapril on systolic and diastolic cardiac function in hypertensive patients.
    Schneeweiss A; Green T; Krakuer J; Goldhamer E; Szucs T; Marmor A
    J Hum Hypertens; 1989 Aug; 3(4):251-4. PubMed ID: 2529375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term beneficial effects of endralazine, a new arteriolar vasodilator at rest and during exercise capacity in chronic congestive heart failure.
    Quyyumi AA; Wagstaff D; Evans TR
    Am J Cardiol; 1984 Nov; 54(8):1020-4. PubMed ID: 6496323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single dose of cilazapril improves diastolic function in hypertensive patients.
    Marmor A; Green T; Krakuer J; Szucs T; Schneeweiss A
    Am J Med; 1989 Dec; 87(6B):61S-63S. PubMed ID: 2532463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acute and chronic cilazapril treatment in spontaneously hypertensive rats.
    Fischli W; Hefti F; Clozel JP
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):151S-158S. PubMed ID: 2527529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The acute and chronic effects of cilazapril on cardiac function in hypertensive patients.
    Schneeweiss A; Marmor A
    Kardiol Pol; 1990; 33(8):13-6. PubMed ID: 2150081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE; Sims R; Noakes TD
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antihypertensive treatment with cilazapril. Resting and exercise blood pressure, hormones and enzymes.
    Breithaupt K; Belz GG; Spielmanns DG; Neis W; Kirchner P
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):136-41. PubMed ID: 2159308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the effects of cilazapril and captopril versus placebo on exercise testing in chronic heart failure patients: a double-blind, randomized, multicenter trial. The Cilazapril-Captopril Multicenter Group.
    Cardiology; 1995; 86 Suppl 1():34-40. PubMed ID: 7614505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of the acute and chronic effects of cilazapril and hydrochlorothiazide on diastolic cardiac function in hypertensive patients.
    Schneeweiss A; Rosenthal J; Marmor A
    J Hum Hypertens; 1990 Oct; 4(5):535-9. PubMed ID: 2149388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cilazapril: a new non-thiol-containing angiotensin-converting enzyme inhibitor. Worldwide clinical experience in hypertension.
    Kögler P
    Am J Med; 1989 Dec; 87(6B):50S-55S. PubMed ID: 2532461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.